Concepedia

Wanlong Lin

WL

4

Publications

75

Citations

4

H-Index

2019

Active since

Affiliations

Xiamen University(Current)

Wanlong Lin is an author at Xiamen University specializing in pharmacoepidemiology, patient safety, and reliability.

Top concepts

Publications per year

2019–2024

4

Publications

4

Comparative analysis of adverse events associated with CDK4/6 inhibitors based on FDA’s adverse event reporting system: a case control pharmacovigilance study

Wanlong Lin, Yanbin Zeng, Lizhu Weng et al. · BMC Pharmacology and Toxicology · 2024 · 27 citations · Full text

Evaluation of a medication error monitoring system to reduce the incidence of medication errors in a clinical setting

Yao Chen, Xingdong Wu, Zhiyi Huang et al. · Research in Social and Administrative Pharmacy · 2019 · 19 citations

, , +10

Optimal exposure targets for vancomycin in the treatment of neonatal coagulase-negative Staphylococcus infection: A retrospective study based on electronic medical records

Quanyao Chen, Jun Wan, Wei Shen et al. · Pediatrics & Neonatology · 2022 · 17 citations · Full text

Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system

Wanlong Lin, Jiabing Xu, Yu‐Fang Liao et al. · International Journal of Clinical Pharmacy · 2023 · 12 citations

Rows per page

1–4 of 4